A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells

作者：Yamada Tohru; Mehta Rajeshwari R; Lekmine Fatima; Christov Konstantin; King Marissa L; Majumdar Dibyen; Shilkaitis Anne; Green Albert; Bratescu Laura; Beattie Craig W; Gupta Tapas K Das^*

来源：Molecular Cancer Therapeutics, 2009, 8(10): 2947-2958.

DOI：10.1158/1535-7163.MCT-09-0444

We report that amino acids 50 to 77 of azurin (p28) preferentially enter the human breast cancer cell lines MCF-7, ZR-75-1, and T47D through a caveolin-mediated pathway. Although p28 enters p53 wild-type MCF-7 and the isogenic p53 dominant-negative MDD2 breast cancer cell lines, p28 only induces a G(2)-M-phase cell cycle arrest and apoptosis in MCF-7 cells. p28 exerts its antiproliferative activity by reducing proteasomal degradation of p53 through formation of a p28:p53 complex within a hydrophobic DNA-binding domain (amino acids 80-276), increasing p53 levels and DNA-binding activity. Subsequent elevation of the cyclin-dependent kinase inhibitors p21 and p27 reduces cyclin-dependent kinase 2 and cyclin A levels in a time-dependent manner in MCF-7 cells but not in MDD2 cells. These results suggest that p28 and similar peptides that significantly reduce proteasomal degradation of p53 by a MDM2-independent pathway(s) may provide a unique series of cytostatic and cytotoxic (apoptotic) chemotherapeutic agents. [Mol Cancer Ther 2009;8(10):2947-58]

• 出版日期2009-10